Average length of a clinical trial cycle 2014-2022
This statistic shows the development of the average length of a clinical trial cycle from 2014 to 2022. The data is based on 12 large-cap and four mid-to-large-cap biopharma companies worldwide and across five major therapy areas: oncology, central nervous system, infectious diseases, metabolic disorders, and cardiovascular. As can be seen, the average length of trials increased with a peak of 7.14 years in 2020.